Vascular surgery


Vascular surgery

The haemostasis properties of Vivostat® products and their strong adhesion even in wet environments makes a good fit for vascular surgery and graft implantation.

Surgeons find Vivostat® Fibrin and Vivostat® PRF most useful for the following surgical procedures:

  • Abdominal aortic resection
  • Thoracis aorta
  • Thoraco – abdominal aortic
  • Aortobifemoral bypass
  • Carotid resection
  • Kidney and liver transplantations

Vascular surgeons use Vivostat® Fibrin and Vivostat® PRF because of their exceptional elastic and adhesive performance on the graft surface and its ability to improve haemostasis. With these product characteristics it is possible to protect the anastomosis and reduce the risk of re-operations.

main advantages using vivostat®

Vivostat® Fibrin: autologous fibrin outperforming other fibrin sealants in key parameters such as polymerization, elasticity, adhesion, and its impact on tissue.

Vivostat® PRF: all the great key parameters as Vivostat® Fibrin – but with regenerative properties.


Vivostat® in vascular surgery

Click on the video and see the Vivostat® System in use in vascular surgery.


The Vivostat® System deliver the perfect platform for surgeons to control infections locally. With the Vivostat® Co-Delivery system, surgeons can deliver medications together with the sealant/matrix directly to the surgical site. Also, studies have shown that delivering e.g. antibiotics with the Vivostat® products will give the medication the same slow release as the product and the area is therefore treated over time.

Vivostat® Fibrin

Our autologous fibrin show best-in-market results on parameters such as time to haemostasis, elasticity, adhesion to and impact on tissue. 

Vivostat® PRF

Using the Vivostat® System, you can prepare autologous platelets with multiple growth factors embedded in a matrix. 

Aper, T., Wilhelmi, M., Gebhardt, C., Hoeffler, K., Benecke, N., Hilfiker, A., & Haverich, A. (2016), Novel method for the generation of tissue-engineered vascular grafts based on a highly compacted fibrin matrix, Acta Biomaterialia, 29, 21–32,